Evidence map›Paper›PMID 40702652›Full record

ArticleClinical and translational medicine2025

Early molecular changes predict cancer cachexia in LKB1-deleted mouse models of NSCLC.

Gloriana Ndembe, Andrea David Re Cecconi, Federica Palo, Dorina Belotti, Laura Sala, Selena Foroni, Eugenio Scanziani, Rosanna Piccirillo, Massimo Broggini, Mirko Marabese

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gloriana NdembeLaboratory of Molecular Pharmacology, Experimental Oncology Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Andrea David Re CecconiLaboratory of Muscle Pathophysiology, Neuroscience Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Federica PaloLaboratory of Muscle Pathophysiology, Neuroscience Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Dorina BelottiLaboratory of Tumor Microenvironment, Experimental Oncology Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Laura SalaDepartment of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.
Selena ForoniLaboratory of Molecular Pharmacology, Experimental Oncology Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Eugenio ScanzianiDepartment of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.
Rosanna PiccirilloLaboratory of Muscle Pathophysiology, Neuroscience Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Massimo BrogginiLaboratory of Molecular Pharmacology, Experimental Oncology Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0002-8138-9358
Mirko MarabeseLaboratory of Molecular Pharmacology, Experimental Oncology Department, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Funding

Associazione Italiana per la Ricerca sul Cancro IG-24347
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40702652
PMCPMC12286895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.